Irene B Helenowski
Overview
Explore the profile of Irene B Helenowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
1523
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Tariq H, Slonim L, Coty Fattal Z, Alikhan M, Segal J, Gurbuxani S, et al.
Br J Haematol
. 2022 Mar;
197(6):736-744.
PMID: 35304738
Therapy-related myeloid neoplasms (t-MNs) are a complication of treatment with cytotoxic chemotherapy and/or radiation therapy. The majority of t-MNs show chromosomal abnormalities associated with myelodysplastic syndrome (MDS) or KMT2A rearrangements...
12.
Goodman M, Lo S, Yadav D, Wu B, Jamil L, Kwok K, et al.
Pancreas
. 2022 Feb;
51(1):e10-e12.
PMID: 35195610
No abstract available.
13.
Schumacher F, Helenowski I, Oswald L, Gonzalez B, Benning J, Morgans A
Patient Prefer Adherence
. 2022 Feb;
16:235-244.
PMID: 35125865
Background: Multiple treatments for metastatic prostate cancer have similar efficacy, leaving patients with complicated treatment choices. Shared decision-making can facilitate difficult treatment decisions, but the extent to which this is...
14.
Jackson M, Ludi E, Reitz A, Moraes Dos Santos G, Helenowski I, Quiroga L, et al.
J Surg Res
. 2022 Jan;
273:1-8.
PMID: 34999516
Background: The aim of this study is to assess the efficacy of the TRUE-Bolivia (Trauma Responders Unifying to Empower Communities Bolivia) trauma first responder course at improving participant confidence in...
15.
Burt R, Han X, Quigley K, Helenowski I, Balabanov R
J Neurol
. 2021 Oct;
269(5):2513-2526.
PMID: 34633525
Objective: To investigate the results of real-world application of non-myeloablative autologous HSCT for multiple sclerosis (MS). Methods: Between July 2003 and October 2019 at a single center (Northwestern University), 414...
16.
Hekman K, Chao C, Morgan C, Helenowski I, Eskandari M
Vascular
. 2021 Sep;
30(6):1199-1204.
PMID: 34569367
Objective: Optimal medical therapy for acute lower extremity deep venous thrombosis (DVT) remains an enigma. While clinical trials demonstrate non-inferiority with an oral anti-Xa inhibitor, or direct oral anticoagulant (DOAC),...
17.
Pamulapati V, Guitart J, Helenowski I, Resnick S, Ho K
Vasc Med
. 2021 Jul;
26(5):566-568.
PMID: 34269145
No abstract available.
18.
Chow K, Kurumety S, Helenowski I, Giri S, Sturgeon C
Surgery
. 2021 Mar;
170(2):462-468.
PMID: 33648765
Background: Remnant radioiodine ablation is discouraged in low-risk differentiated thyroid cancer because it confers no survival advantage. The impact of remnant radioiodine ablation on health-related quality of life in these...
19.
Burt R, Han X, Quigley K, Arnautovic I, Shah S, Lee D, et al.
Bone Marrow Transplant
. 2020 Jul;
56(1):50-59.
PMID: 32612255
We compared three fludarabine-based regimens for systemic sclerosis patients with a high-risk cardiac phenotype that according to EBMT criteria would be a contraindication for a high-dose cyclophosphamide (200 mg/kg) transplant...
20.
Khanh L, Helenowski I, Hoel A, Ho K
Ann Vasc Surg
. 2020 Jun;
69:206-216.
PMID: 32502672
Background: The comorbidity-polypharmacy score (CPPS) was developed to quantify the severity of comorbidities of patients with geriatric trauma. CPPS is the sum of the number of medications and comorbidities, and...